Medicinal Products

95. Deputy Pádraig O'Sullivan asked the Minister for Health the progress her Department has made in honouring the Programme for Government commitment that an early access programme for medicines would be established; and if she will make a statement on the matter. [34979/25]

197. Deputy Colm Burke asked the Minister for Health if she will prioritise the Programme for Government commitment to investigate early access schemes for orphan medicines; and if she will make a statement on the matter. [34701/25]

787. Deputy Robert O'Donoghue asked the Minister for Health if there are plans to change the timely access to the drug givinostat required to help treatment for persons with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33827/25]

799. Deputy Martin Daly asked the Minister for Health if there are plans to introduce skyclarys (omaveloxolone) into the Irish market for the treatment of Friedreich's ataxia in adults and adolescents; which is approved in America, Canada, UK, some European countries but not Ireland to date; and if she will make a statement on the matter. [33909/25]

832. Deputy Willie O'Dea asked the Minister for Health if she will accelerate the approval and funding of the new drug givinostat to treat the one-hundred boys currently living with Duchenne muscular dystrophy in Ireland; and if she will make a statement on the matter. [34122/25]

385. Deputy Robert O'Donoghue asked the Minister for Health if she will address the situation regarding the unavailability of phyllocontin and uniphyllin (theophylline) tablets, which were previously used to manage asthma and were covered under the medical card scheme; if uniphyllin continus PR, which is believed to be the replacement, will be made available under the medical card given its high m…

388. Deputy Aisling Dempsey asked the Minister for Health the actions she will take to ensure that givinostat is available at the earliest opportunity to sufferers of Duchenne muscular dystrophy. [33245/25]

402. Deputy Albert Dolan asked the Minister for Health if she will provide an update on the current status of the approval process for the drug givinostat for patients with Duchenne muscular dystrophy; if consideration is being given to its inclusion in an early access programme, similar to those operating in the United Kingdom and the United States; and if she will make a statement on the matter.…

403. Deputy Ruth Coppinger asked the Minister for Health to outline her engagements with the HSE on access to givinostat for Duchenne muscular dystrophy; and if she will make a statement on the matter. [33325/25]

412. Deputy Eoin Ó Broin asked the Minister for Health if she will use her power to ensure a decision is made as a matter of urgency regarding an application for reimbursement of new medicines (details supplied) given lengthy reimbursement times and the detrimental impact delaying access to this medicine has on the medical condition to which it relates. [33380/25]

423. Deputy Barry Heneghan asked the Minister for Health the steps she is taking to ensure that a drug (details supplied) will be assessed and made available as quickly as possible following its recent EU approval, given how important early access is for children with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33451/25]

141. Deputy Seán Ó Fearghaíl asked the Minister for Health if she will address concerns outlined in correspondence (details supplied) regarding the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [32876/25]

143. Deputy Mark Ward asked the Minister for Health if she will meet members of the group who made a presentation on Duchenne muscular dystrophy on 11 June 2025 in Leinster House as they try to access a new drug called givinostat; and if she will make a statement on the matter. [32910/25]

150. Deputy Brendan Smith asked the Minister for Health to report on the progress being made regarding the provision of givinostat (brand name duvyzat) for the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [32923/25]

153. Deputy Eoin Hayes asked the Minister for Health when all adults living with spinal muscular atrophy will be entitled to the same treatments as children living with spinal muscular atrophy in Ireland; and if she will make a statement on the matter. [32936/25]

156. Deputy Claire Kerrane asked the Minister for Health if she will seek access to the early access programme for givinostat for patients with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33019/25]

165. Deputy Claire Kerrane asked the Minister for Health if patients with Duchenne muscular dystrophy will have access to the early access programme for givinostat; and if she will make a statement on the matter. [33077/25]

167. Deputy Roderic O'Gorman asked the Minister for Health to provide an update on the health technology assessment being carried out on the orphan medicine givinostat (brand name duvyzat) used to treat Duchenne muscular dystrophy; if there are any steps she can take to speed up the assessment process; and if she will make a statement on the matter. [33092/25]

741. Deputy Cathal Crowe asked the Minister for Health when the medication known as givinostat will be made available in Ireland, given its potential role in the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [31801/25]

746. Deputy Richard Boyd Barrett asked the Minister for Health whether she will intervene to ensure that a person (details supplied) with Duchenne muscular dystrophy can be prescribed givnostat as a matter of urgency. [31826/25]

747. Deputy Michael Healy-Rae asked the Minister for Health if the drug givinostat will be approved in Ireland (details supplied); and if she will make a statement on the matter. [31827/25]

759. Deputy Erin McGreehan asked the Minister for Health if she will provide details regarding the prescribing of antidepressants to patients who are covered under the medical card scheme and the drugs payment scheme; and if she will make a statement on the matter. [31852/25]

773. Deputy John Brady asked the Minister for Health if she will make the drug givinostat available to all who are diagnosed with Duchenne Muscular Dystrophy; if so, whether she will provide a timeline for the rollout of this drug; and if she will make a statement on the matter. [31934/25]

807. Deputy Shane Moynihan asked the Minister for Health when medication known as givinostat will be made available in the State, given the role it can play in treating Duchenne muscular dystrophy in young boys. [32084/25]

827. Deputy Seán Canney asked the Minister for Health if she will expedite the process of approval for givinostat, used in the treatment of Duchenne Muscular Dystrophy, as further delays could affect the ability of patients to retain muscular strength and the current process for drug approval in Ireland can take on average 617 days, during which time muscular dystrophy patients will have lost sign…